Safety results showed a higher incidence of pneumonia in the triple therapy group than in the group receiving dual therapy of LAMA and LABA, with a significant trend to increase pneumonia incidence when compared with LAMA monotherapy (which did not increase incidence significantly).
← all excerpts
Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis.
1
—
—